Morphine potentiates HIV-1 gp120-induced neuronal apoptosis.

To investigate the effect of opiates on human immunodeficiency virus type 1 (HIV-1)-related neuronal apoptosis, primary human fetal neuronal/glial cell cultures were exposed to gp120(IIIB) in the absence and the presence of morphine. Although morphine by itself had little effect on neuronal survival, the combination of morphine (>/=10(-7) mol/L) and gp120(IIIB) (1 nmol/L) significantly increased neuronal apoptosis. The mechanism whereby morphine potentiates gp120(IIIB)-induced neuronal apoptosis appears to involve activation of the p38 mitogen-activated protein kinase intracellular signaling pathway and microglial cells dispersed within the neuronal/glial cell cultures. These results provide additional insight into the molecular basis whereby opiate abuse could promote HIV-1-associated dementia.

[1]  C. Newton,et al.  Microbial Infections, Immunomodulation, and Drugs of Abuse , 2003, Clinical Microbiology Reviews.

[2]  A. Nath,et al.  Molecular Basis for Interactions of HIV and Drugs of Abuse , 2002, Journal of acquired immune deficiency syndromes.

[3]  H. Xiong,et al.  HIV‐1‐Associated Dementia: A Metabolic Encephalopathy Perpetrated by Virus‐Infected and Immune‐Competent Mononuclear Phagocytes , 2002, Journal of acquired immune deficiency syndromes.

[4]  Shuxian Hu,et al.  Morphine induces apoptosis of human microglia and neurons , 2002, Neuropharmacology.

[5]  B. Kasinath,et al.  Role of P38 Mitogen-Activated Protein Kinase Phosphorylation and Fas-Fas Ligand Interaction in Morphine-Induced Macrophage Apoptosis1 , 2002, The Journal of Immunology.

[6]  Stuart A. Lipton,et al.  Pathways to neuronal injury and apoptosis in HIV-associated dementia , 2001, Nature.

[7]  J. Zhang,et al.  Synergistic neurotoxicity of opioids and human immunodeficiency virus-1 Tat protein in striatal neurons in vitro , 2001, Neuroscience.

[8]  Tomlinson,et al.  Upregulation of microglia in drug users with and without pre‐symptomatic HIV infection , 1999, Neuropathology and applied neurobiology.

[9]  P. Simmonds,et al.  HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. , 1998, Brain : a journal of neurology.

[10]  O. Selnes,et al.  Variable progression of HIV‐associated dementia , 1998, Neurology.

[11]  T. Eisenstein,et al.  Opioid modulation of immune responses: effects on phagocyte and lymphoid cell populations , 1998, Journal of Neuroimmunology.

[12]  P. Lantos,et al.  HIV‐associated brain pathology in the United Kingdom: an epidemiological study , 1997, AIDS.

[13]  K. Shark,et al.  Activation of Mu Opioid Receptors Inhibits Microglial Cell Chemotaxis 1 , 2022 .

[14]  K. Williams,et al.  Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. , 2002, Annual review of neuroscience.

[15]  E. Vittinghoff,et al.  Incidence proportion of and risk factors for AIDS patients diagnosed with HIV dementia, central nervous system toxoplasmosis, and cryptococcal meningitis. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.